Goto

Collaborating Authors

Real Time Systems


Top 3 Considerations For Enterprise IoT Security

#artificialintelligence

Enterprise IoT, those connected devices you increasingly find on your organization's network like printers, VoIP phones, smart boards and TVs inside your network, is growing at a massive rate and is expected to reach USD 58 billion by 2023. These devices represent an uncontrolled risk that the majority of organizations don't have visibility into. The next generation of IoT is becoming more than a group of devices, and has morphed into mission critical enterprise-wide services that leverage edge-computing and modern hybrid architectures. This new paradigm requires high levels of uptime and most importantly improved security measures. Further exacerbating the risk, IoT and Security teams seldom, if ever, collaborate on IoT strategy and deployment.


Perimeter Medical Imaging Announces Expansion of ATLAS AI Project with Installation of OTISTM for AI development at Leading Cancer Care Center, MD Anderson

#artificialintelligence

DALLAS, TX / ACCESSWIRE / July 27, 2020 / Perimeter Medical Imaging, AI Inc. (TSXV:PINK) today announced the installation of their OTISTM device at the University of Texas MD Anderson Cancer Center (MD Anderson), to further develop ImgAssist AI technology marking an important milestone in this collaboration and Perimeter's ATLAS AI Project. Initiated in mid-July, the ATLAS AI Project allows Perimeter to collaborate with industry-leading cancer care centers that will use OTIS - its proprietary ultra-high resolution imaging platform - to collect images of breast tumors from approximately 400 patients for the purpose of training and testing Perimeter's ImgAssist AI technology. This technology, which is currently under development, is designed to utilize a machine learning model to help surgeons identify, in real-time, if cancer is still present when performing breast-conserving surgery (lumpectomy). This study was made possible, in part, by a $7.4 million grant awarded by the Cancer Prevention and Research Institute of Texas (CPRIT), a leading state body funding cancer research. Jeremy Sobotta, President and CFO stated, "Initiation at MD Anderson is an important milestone in part one of our ATLAS AI Project and marks the next step in our development and clinical validation efforts for our ImgAssist AI software. MD Anderson is one of the largest breast cancer centers in the United States, treating approximately 40,000 patients a year, and is a valued collaborator as we strive to help physicians improve surgical outcomes for breast cancer patients by providing an additional tool for real-time margin visualization and assessment."


Global Big Data Conference

#artificialintelligence

MCG Health, part of the Hearst Health network, announces it has successfully piloted its new machine learning solution, Indicia for Effective Focus, and it is now available for licensing. MCG is partnering with five major hospital systems for continued development and enhancement of this solution: Avera McKennan Hospital, Baptist Health System, Erlanger Health System, Franciscan Alliance, and IU Health. Indicia for Effective Focus prioritizes utilization management worklists based on the probability of appropriate patient placement, as well as the potential negative financial impact due to untimely decision making. The platform leverages MCG's extensive clinical evidence base, real-time data from the EHR (electronic health record), and machine learning technology to guide the case prioritization. Crissa Mulkey, Director of Utilization Management at IU Health said, "Indicia for Effective Focus shows an intuitive understanding of UM users, as well as how UM, or utilization review, is performed. It is a refreshing change."


ComplyAdvantage nabs $50M for an AI platform and database to detect and stop financial crime – TechCrunch

#artificialintelligence

The growth of digital banking has opened up a wealth of opportunities for making the world of finance more accessible and transparent to a greater number of people. But the darker underbelly is that it has also created more avenues for illicit activity to flourish, with some $2 trillion laundered annually but only 1-3% of that sum "caught". To help combat that, a London-based startup called ComplyAdvantage, which has built an AI platform and wider database of some 10 million entities to help identify and track those involved in financial crime, is today announcing a growth round of funding of $50 million expand its reach and operations. Specifically, the plan will be to use the funding for hiring, to invest in the tools it uses to detect entities and map the relationships between them, and to bring on more clients. "We've been focused on more granular analysis and being able to scale to hundreds of millions of searches across our database," said Charles Delingpole, founder and CEO, said in an interview.


arebyte Gallery: Real-Time Constraints

#artificialintelligence

Usually, you pop up in an exhibition, coming from vivid streets to the Silent Hall of art. The exhibition pops up where you are, suddenly, amidst your next Zoom call, or while you are checking your emails. And you are exposed to it. In these crazy pandemic times, they found a perfect way to present art, without put the visitors in danger to be Corona'ed: Plug-In. You install a plug-in to your browser, and every hour another artwork overfloods your PC windows.


4 Ways To Leverage Industrial IoT - Express Computer

#artificialintelligence

The fourth wave of the industrial revolution, known as Industry 4.0, connects industrial devices and permits organizations to use arranged information from IoT gadgets and PC controlled frameworks. Applying Artificial Intelligence (AI) and Machine Learning (ML) to this information makes fully automated smart factories, smart cities and more. Industry 4.0 is all about being digitally enabled and data driven, bringing together new technologies and compute services across edge and cloud assets to drive productivity, create new business models, and innovate faster. These technologies include everything from advanced analytics and AI to augmented reality, digital twins, and industrial IoT platforms, and, together serve the core needs of the manufacturing sector. IoT and Industrial IoT power mission-critical applications that require high reliability and unwavering quality.


5G And Machine Learning: Taking Cellular Base Stations From Smart To Genius

#artificialintelligence

An illuminated 5G sign hangs behind a weave of electronic cables on the opening day of the MWC ... [ ] Barcelona in Barcelona, Spain, on Monday, Feb. 25, 2019. At the wireless industry's biggest conference, over 100,000 people are set to see the latest innovations in smartphones, artificial intelligence devices and autonomous drones exhibited by more than 2,400 companies. At the core of this evolutionary step is the use of machine learning algorithms. The ability to be more dynamic with real-time network optimization capabilities such as resource loading, power budget balancing and interference detection is what made networks "smart" in the 4G era. While there are many uses of machine learning across all layers of a 5G network from the physical layer through to the application layer, the base station is emerging as a key application for machine learning.


3 Artificial Intelligence Stocks With Long-Term Narratives

#artificialintelligence

Artificial intelligence (AI) is a buzzword in tech these days. The term, which encompasses a range of technologies including machine learning and data analysis. The goal is to create systems that can perceive, learn, and reason in ways that mimic human capabilities. At its best, AI will allow machines to understand the gestalt of a situation and react accordingly, a capability that humans take for granted – but has tends to elude computer systems, which in their turn excel at analyzing minute details. A wide range of tech companies are working on AI systems; artificial intelligence holds the promise of real-time data analysis and situation monitoring, with the machines capable of handling routine decisions.


This Al Gore-supported project uses AI to track the world's emissions in near real time

#artificialintelligence

"Although scientists have a good understanding how much carbon is in the atmosphere, it's surprisingly tough to trace where those emissions come from," says Gavin McCormick, the founder of a nonprofit called WattTime that also makes technology that enables smart devices to automatically reduce emissions. The startup is working with several other climate and tech organizations and the former vice president Al Gore on the new project. Right now, McCormick says, most emissions data is self-reported, and it can sometimes take years for the data to be gathered. "We think that technology, in particular AI and satellites, have the potential to change that pretty profoundly, which can influence sort of any sector that depends on really knowing where emissions are coming from to make good decisions," he says. "The time lag in current data makes it often non-actionable," says Gore, who has been helping structure the project to have the maximum impact on the climate crisis and enlisting partners for financial and strategic support.


3 Artificial Intelligence Stocks With Long-Term Narratives

#artificialintelligence

Artificial intelligence (AI) is a buzzword in tech these days. The term, which encompasses a range of technologies including machine learning and data analysis. The goal is to create systems that can perceive, learn, and reason in ways that mimic human capabilities. At its best, AI will allow machines to understand the gestalt of a situation and react accordingly, a capability that humans take for granted – but has tends to elude computer systems, which in their turn excel at analyzing minute details. A wide range of tech companies are working on AI systems; artificial intelligence holds the promise of real-time data analysis and situation monitoring, with the machines capable of handling routine decisions. While it hasn’t been achieved yet, the outlines of success are visible on the horizon. Every smart investor knows to keep his eyes on the horizon; that is, to plan every investment with long-range intentions. Just how long is up to the individual, but most investors agree that a move isn’t long-term unless it’s held for more than one year. Warren Buffett has famously said, “If you are not willing to own a stock for 10 years, do not even think about owning it for 10 minutes.” With this in mind, we used TipRanks' database to identify three AI stocks that have been highlighted by some of Wall Street’s best tech sector analysts. These are analysts with 5-star ratings, standing above their peers in accuracy and average returns – and they’ve tapped Artificial Intelligence as a tech segment for the long run. Veritone, Inc. (VERI) We’ll start with Veritone. This media tech company offers a cloud-based operating system for AI that uses machine learning to turn data into useful intelligence. The software allows users to process audio and video in real time, enhance analytics and research apps, reduce content review times, and streamline time spent on ‘low-value, high-effort’ tasks. The value of the product to the customers can be seen in the quarterly earnings trends and the share appreciation. The last six months – covering the worst of the global pandemic and economic recessionary pressures – have seen VERI’s earnings steadily improve and the share price rise to its best level in over two years. Earlier this month, Veritone showed its confidence by adjusting its Q2 revenue guidance upwards. The guidance, of $13.1 to $13.3 million, is well above the previous upper guide of $12.2 million. The share price has tracked the gains in revenue and earnings. The stock has more than doubled since the February/March market collapse, rising from $3.03 to $10.83 now. Patrick Walravens, writing from JMP Securities, was impressed by Veritone’s new revenue guidance, and reiterated his Buy rating on the stock. In his comments, he said, “Veritone seems to be gaining traction in its Government, Legal, and Compliance verticals as it experienced record bookings in the quarter… we believe the company is moving its cost structure in the right direction with recent cost-reduction initiatives and upgrades…” With his $17 price target, Walravens shows his own confidence that VERI will see 57% growth in the year ahead. (To watch Walravens’ track record, click here) Overall, VERI’s Moderate Buy analyst consensus rating is based on 4 Buys and just a single Sell. The stock’s current price is $11.80, and the average price target $16.25 suggests it has a 50% upside potential. Note that even the low-ball target estimate, of $15, is well above the current price. (See Veritone stock analysis on TipRanks) ZoomInfo Technologies (ZI) Next up is ZoomInfo, a marketing tech company. ZI offers the usual features and services that customers expect in digital marketing intelligence, including account management, data management, demand generation, and lead prospecting. The company’s AI cloud software is specifically designed to improve efficiency in these tasks, letting sellers get to the business of selling. ZoomInfo is a newly public company, having held its IPO just this past June. The opening was a success, with share prices almost doubling on the first day and nearly tripling in the first few trading sessions. Even now, after nearly two months during which the initial excitement waned and the glow came off the rose, the stock is still trading 88% above its initial price of $21. The strong IPO prompted SunTrust Robinson analyst Terry Tillman – who is rated in the top 10 of the TipRanks analyst database – to initiate coverage of the stock with a Buy rating. Tillman wrote of ZoomInfo, “We believe ZoomInfo represents a rare combination of strong top-line growth and best-in-class profitability. Its go-to-market (GTM) sales intelligence platform drives positive outcomes for B2B sales and marketing organizations - increasing leads, customers and revenue. Premium valuation justified owing to accelerating demand for GTM intelligence and company-specific drivers leading to significant revenue and profit upside.” Tillman’s Buy rating comes with a $60 price target, implying an impressive 51% upside potential. (To watch Tillman’s track record, click here) ZoomInfo holds a Moderate Buy rating from the analyst consensus. This is based on 16 reviews, including 7 Buys and 9 Holds. The stock’s $55.07 average price target suggests it has room for 32% growth from the $41.66 trading price this year. (See ZoomInfo stock analysis on TipRanks) CareDx (CDNA) Last on today’s list is a tech company in the health care sector. CareDx develops and delivers diagnostic surveillance systems for heart transplant patients. The company’s AI-powered software monitors patient progress in real time, allowing both the patient and the doctors to respond to any rapidly changing health issues in time to ensure a more successful outcome. The result is a novel development in long-term care. While CareDx’s products were originally designed to monitor heart transplants, the company has expanded. Its products now monitor most human organ transplants – including kidneys, an important niche, as the first successful organ transplant was conducted with a kidney, and this procedure is still among the most common of transplants. CareDx also has cloud-based AI systems to monitor lab results, and to connect digital implants with remote monitors. The company’s earnings have proven mostly immune to recent economic instability, as medical transplant patients and doctors cannot simply stop using the monitoring systems. And with a firm user base, the stock recovered well from the late-winter market crash. CDNA is up over 130% since bottoming out in March. Covering the stock for Piper Sandler, analyst Steven Mah wrote, “We believe CareDx has the broadest transplant care platform in the industry and we remain confident that it is well-positioned to protect and extend its first-mover advantage in both pre- and post-transplant patient management to drive long-term growth. In addition, we are encouraged by the resiliency of its essential tests and ability to operate in a COVID-19 environment.” Mah gives CDNA a Buy rating, along with a $54 price target that implies an upside of 66% for the next 12 months. (To watch Mah’s track record, click here) All in all, with 4 recent reviews on record, all Buys, CareDx has a unanimous Strong Buy rating from the analyst consensus. The stock is currently selling for $32.59, and the average price target, at $42.75, suggests a one-year upside of 31%. (See CareDx stock-price forecast on TipRanks) To find good ideas for tech stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.